Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2000 2
2003 2
2007 1
2009 1
2011 1
2012 1
2016 1
2018 1
2019 3
2020 3
2021 1
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration.
Izquierdo-Serra J, Martin-Pinardel R, Moll-Udina A, Bernal-Morales C, Garay-Aramburu G, Sanchez-Monroy J, Arruabarrena C, Fernandez-Hortelano A, Figueroa MS, Abraldes M, Lavid de Los Mozos FJ, Zapata MA, Ruiz-Moreno JM, Broc-Iturralde L, Gonzalez-Guijarro J, Escobar-Barranco JJ, Gallego-Pinazo R, Parrado-Carrillo A, Dotti-Boada M, Alforja S, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J; Writing Committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group. Izquierdo-Serra J, et al. Among authors: gonzalez guijarro j. Ophthalmol Retina. 2024 Apr;8(4):350-359. doi: 10.1016/j.oret.2023.10.022. Epub 2023 Nov 2. Ophthalmol Retina. 2024. PMID: 37924946
Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy.
Moll-Udina A, Miguel Escuder L, Hernanz I, Llorenç V, Fonollosa A, Cordero Coma M, Sainz de la Maza M, Espinosa G, González Guijarro JJ, Lopez Lopez F, Alba-Linero C, Hernández M, Martínez Costa L, Celdrán Vivancos D, Giralt L, Artaraz J, Soler Bartrina P, Jódar Márquez M, García de Vicuña R, Esquinas C, Adán A. Moll-Udina A, et al. Among authors: gonzalez guijarro jj. Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1591-1598. doi: 10.1080/09273948.2020.1769139. Epub 2020 Jul 13. Ocul Immunol Inflamm. 2021. PMID: 32657649
PCR Multiplex for CMV Detection in Patients with Anterior Uveitis.
Martín Ramírez A, Cardeñoso Domingo L, González Guijarro JJ. Martín Ramírez A, et al. Among authors: gonzalez guijarro jj. Ocul Immunol Inflamm. 2019;27(2):197-202. doi: 10.1080/09273948.2018.1438633. Epub 2018 Feb 23. Ocul Immunol Inflamm. 2019. PMID: 29474137
Diagnostic and therapeutic challenges.
Pérez-Alvarez MJ, González-Guijarro J, Adán-Civera A, Moreno-López M, Williams DF, Nguyen QD. Pérez-Alvarez MJ, et al. Among authors: gonzalez guijarro j. Retina. 2007 Apr-May;27(4):509-13. doi: 10.1097/IAE.0b013e31804b3d44. Retina. 2007. PMID: 17420707 No abstract available.
Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group.
Llorenç V, Cordero-Coma M, Blanco-Esteban A, Heras-Mulero H, Losada-Castillo MJ, Jovani-Casano V, Valls-Pascual E, Jodar-Marquez M, García-Aparicio Á, Fonollosa A, González-Guijarro JJ, Rodriguez-Melian L, Fernández-Prada M, Jerez-Fidalgo M, Hernandez-Garfella M, Esquinas C, Sainz-de-la-Maza M, Adán A; Biotherapies in Uveitis (BioÚvea) Study Group. Llorenç V, et al. Among authors: gonzalez guijarro jj. Ophthalmology. 2020 Jun;127(6):814-825. doi: 10.1016/j.ophtha.2019.11.024. Epub 2019 Dec 2. Ophthalmology. 2020. PMID: 31952883 Free article.
17 results